Loews Corp Pfizer Inc Transaction History

Loews Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $7.84 Million - $10.2 Million	300,000 New	300,000 $8.64 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $11.4 Million - $14.2 Million	-250,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $2.07 Million - $3.06 Million	-50,000 Reduced 16.67%	250,000 $14.8 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $11.8 Million - $15.1 Million	300,000 New	300,000 $12.9 Million
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $279,409 - $399,214	-10,337 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $125,787 - $142,752	-3,821 Reduced 26.99%	10,337 $405,000
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $208,618 - $270,516	-6,421 Reduced 31.2%	14,158 $509,000
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $145,109 - $162,924	3,924 Added 23.56%	20,579 $891,000
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $213,585 - $243,510	-5,552 Reduced 25.0%	16,655 $727,000
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $8.21 Million - $9.53 Million	-257,340 Reduced 92.06%	22,207 $788,000
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $332,600 - $352,900	-10,000 Reduced 3.45%	279,547 $10.1 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $8.98 Million - $9.89 Million	289,547	289,547 $10.3 Million

3,257

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Loews Corp, based on Form 13F filings with the SEC.

Stay updated on Loews Corp with notifications on news.